Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

12.71
-0.0800-0.63%
Post-market: 12.930.2200+1.73%19:30 EDT
Volume:2.86M
Turnover:36.71M
Market Cap:1.91B
PE:-2.84
High:13.37
Open:13.03
Low:12.58
Close:12.79
52wk High:18.57
52wk Low:7.48
Shares:150.42M
Float Shares:117.99M
Volume Ratio:0.77
T/O Rate:2.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4800
EPS(LYR):-6.8648
ROE:-799.46%
ROA:-71.98%
PB:156.42
PE(LYR):-1.85

Loading ...

Jan 07, 2022

Major Issues Report

8-K - Current report
Dec 30, 2021

Major Issues Report

8-K - Current report
Dec 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2021

Major Issues Report

8-K - Current report
Oct 01, 2021

Major Issues Report

8-K - Current report
Sep 27, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jul 07, 2021

Major Issues Report

8-K - Current report